{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:48:33Z","timestamp":1784746113120,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.clgc.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T04:41:32Z","timestamp":1439268092000},"page":"231-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed"],"prefix":"10.1016","volume":"14","author":[{"given":"Andrea","family":"Necchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Giannatempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-9526","authenticated-orcid":false,"given":"Salvatore","family":"Lo Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2015.08.001_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mds635","article-title":"Penile cancer: current therapy and future directions","volume":"24","author":"Sonpavde","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2015.08.001_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.urolonc.2009.07.017","article-title":"Penile cancer","volume":"27","author":"Salvioni","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2015.08.001_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2015.08.001_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrurol.2015.30","article-title":"Penile cancer: advanced penile cancer continues to elude systemic therapy","volume":"12","author":"Sharma","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2015.08.001_bib5","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemtherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.08.001_bib6","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5-FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2015.08.001_bib7","doi-asserted-by":"crossref","unstructured":"Nicolai N, Sangalli LM, Necchi A, et al. A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and\u00a0Survival Analyses in Neoadjuvant and Adjuvant Settings, Clin Genitourin Cancer 2015 (Epub ahead of print) http:\/\/dx.doi.org\/10.1016\/j.clgc.2015.07.009","DOI":"10.1016\/j.clgc.2015.07.009"},{"key":"10.1016\/j.clgc.2015.08.001_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2015.08.001_bib9","doi-asserted-by":"crossref","unstructured":"Dickstein RJ, Munsell MF, Pagliaro LC, et\u00a0al. Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after pre-operative chemotherapy. BJU Int, Published online October 7, 2014; http:\/\/dx.doi.org\/10.1111\/bju.12946.","DOI":"10.1111\/bju.12946"},{"key":"10.1016\/j.clgc.2015.08.001_bib10","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis","volume":"29","author":"Necchi","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.08.001_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth fator receptor (EGFR) targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2015.08.001_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2015.08.001_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2015.08.001_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","article-title":"Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis","volume":"65","author":"Gunia","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clgc.2015.08.001_bib15","doi-asserted-by":"crossref","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","article-title":"Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas","volume":"6","author":"Stankiewicz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2015.08.001_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/01.pas.0000160440.46394.a8","article-title":"Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases","volume":"29","author":"Velazquez","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2015.08.001_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clgc.2014.08.002","article-title":"Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy","volume":"13","author":"Necchi","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2015.08.001_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3747\/co.v17i1.471","article-title":"EGFR overexpression in squamous cell carcinoma of the penis","volume":"17","author":"Lavens","year":"2010","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clgc.2015.08.001_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.urolonc.2013.10.007","article-title":"Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy","volume":"32","author":"Pond","year":"2014","journal-title":"Urol Oncol"},{"issue":"suppl","key":"10.1016\/j.clgc.2015.08.001_bib20","article-title":"Gene expression profiling to improve prognostic stratification of men with advanced penile squamous cell cancer (PSS) receiving first-line systemic therapy (abstract e15633)","volume":"33","author":"Mehta","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2015.08.001_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clgc.2014.03.009","article-title":"Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma","volume":"12","author":"Pond","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2015.08.001_bib22","doi-asserted-by":"crossref","unstructured":"Sharma P, Djajadiningrat R, Zargar-Shoshtari K, et\u00a0al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol, Published online June 10, 2015; http:\/\/dx.doi.org\/10.1016\/j.urolonc.2015.05.008.","DOI":"10.1016\/j.urolonc.2015.05.008"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767315001974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767315001974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:25:09Z","timestamp":1761564309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767315001974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1558767315001974"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2015.08.001","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}